Lung cancer treatment in India has changed significantly in recent years. For some patients with non-small cell lung cancer (NSCLC), doctors can test the tumor for specific genetic changes and select medicines that target those changes.
This approach is known as targeted therapy. It may be used alongside or instead of other treatments, depending on the cancer type, stage, molecular test results, and the patient’s overall health.
Private cancer hospitals in India may offer molecular testing, precision oncology, targeted medicines, immunotherapy, advanced radiation therapy, and cancer surgery.
Important: Targeted therapy is not suitable for every lung cancer patient. Molecular testing is needed to determine whether an actionable target is present. Treatment decisions should always be made with a qualified oncologist.
What Is Targeted Therapy for Lung Cancer?
Targeted therapy uses medicines designed to act on specific changes that help cancer cells grow and survive.
Unlike traditional chemotherapy, which affects many rapidly dividing cells, targeted medicines are designed to act on particular molecular changes in cancer cells.
Common actionable targets in NSCLC include:
- EGFR
- ALK
- ROS1
- BRAF
- MET
- RET
- NTRK
- KRAS G12C
- HER2
The appropriate medicine depends on the specific genetic alteration, cancer stage, previous treatment, and overall health.
Why Molecular Testing Is Important
Molecular testing helps doctors identify genetic changes in a lung tumor that may affect treatment choices.
Testing may look for:
- EGFR mutations
- ALK rearrangements
- ROS1 rearrangements
- BRAF mutations
- MET alterations
- RET rearrangements
- KRAS G12C mutations
- NTRK alterations
- HER2 alterations
Two patients with the same type of lung cancer may have different molecular profiles. As a result, their treatment plans may also be different.
The goal is to match treatment with the biology of the patient’s cancer.
Major Targeted Therapy Options for Lung Cancer
1. EGFR-Targeted Therapy
EGFR is an important target in NSCLC.
For patients with certain EGFR mutations, doctors may consider medicines such as:
- Osimertinib
- Gefitinib
- Erlotinib
- Afatinib
- Dacomitinib
The choice depends on the specific mutation, cancer stage, previous treatment, and other medical factors.
Osimertinib is one medicine used for certain EGFR-mutated lung cancers and is taken orally.
Patients taking targeted medicines still need regular medical appointments, laboratory tests, and scans to monitor treatment response and possible side effects.
2. ALK-Targeted Therapy
ALK rearrangements are another actionable change found in some NSCLC tumors.
Possible ALK-targeted medicines include:
- Alectinib
- Brigatinib
- Lorlatinib
- Crizotinib
The treatment choice depends on the patient’s individual cancer and previous treatment.
3. ROS1-Targeted Therapy
ROS1 rearrangements can occur in a smaller group of NSCLC patients.
Possible targeted medicines include:
- Crizotinib
- Entrectinib
- Repotrectinib
Doctors consider the patient’s molecular results, previous treatment, and overall condition when selecting therapy.
4. BRAF-Targeted Therapy
Some lung cancers have a BRAF V600E mutation.
For eligible patients, doctors may use a combination of medicines that target the BRAF pathway.
Molecular testing is required to confirm whether the appropriate BRAF mutation is present.
5. MET-Targeted Therapy
Certain MET alterations can be treated with targeted medicines.
Examples include:
- Capmatinib
- Tepotinib
Testing is needed to determine whether the tumor has an alteration that may respond to MET-targeted treatment.
6. RET-Targeted Therapy
RET rearrangements are another actionable alteration in NSCLC.
Targeted medicines may include:
- Selpercatinib
- Pralsetinib
The appropriate treatment depends on the patient’s molecular results and clinical condition.
7. KRAS G12C-Targeted Therapy
KRAS mutations are common in lung cancer, but KRAS G12C is a specific mutation that can be treated with targeted therapy.
Examples include:
- Sotorasib
- Adagrasib
Testing is required to confirm the KRAS G12C mutation.
8. HER2-Directed Treatment
Some lung tumors have HER2 alterations.
Depending on the specific alteration and treatment history, doctors may consider targeted medicines or antibody-drug conjugates.
The treatment should be selected by the patient’s oncology team after reviewing the molecular test results.
Targeted Therapy vs Chemotherapy
| Feature | Targeted Therapy | Chemotherapy |
|---|---|---|
| Main approach | Targets specific molecular changes | Attacks rapidly dividing cells |
| Patient selection | Usually requires an appropriate biomarker | Used in many cancer settings |
| Administration | Often oral, depending on medicine | Often intravenous, but varies |
| Molecular testing | Usually important | Not always required |
| Side effects | Depend on the specific medicine | Can affect healthy rapidly dividing cells |
| Suitable for everyone? | No | No |
| Monitoring | Regular monitoring required | Regular monitoring required |
Targeted therapy is not simply a newer form of chemotherapy. It is a different treatment approach that may be particularly useful when an actionable molecular change is found.
Targeted Therapy vs Immunotherapy
Targeted therapy acts on specific molecular changes in cancer cells.
Immunotherapy helps the immune system recognize and attack cancer cells.
For some lung cancer patients, immunotherapy may be considered based on factors such as:
- PD-L1 status
- Molecular test results
- Cancer stage
- Previous treatment
- Overall health
Not every patient is suitable for immunotherapy.
Advanced Lung Cancer Treatment in India
Depending on the patient’s diagnosis and stage, treatment may include:
- Targeted therapy
- Immunotherapy
- Chemotherapy
- Surgery
- Radiation therapy
- Supportive care
- Clinical trials
A multidisciplinary cancer team may include medical oncologists, thoracic surgeons, radiation oncologists, pulmonologists, pathologists, and radiologists.
Leading Private Hospitals for Lung Cancer Treatment in India
Several private hospital networks provide lung cancer diagnosis and treatment services.
Apollo Cancer Centres
May provide molecular testing, precision oncology, targeted therapy, immunotherapy, radiation, surgery, and multidisciplinary cancer care.
HCG Cancer Centre
Provides cancer diagnosis and treatment through specialist oncology teams and may offer precision oncology and targeted treatment services.
Fortis Memorial Research Institute
Provides oncology services along with access to multiple medical specialties in the Delhi NCR region.
Manipal Hospitals
Provides oncology services through its hospital network, including medical, surgical, and radiation oncology.
Narayana Health
Provides cancer care through multidisciplinary teams and oncology programs in different Indian locations.
Always confirm the availability of a specific test, medicine, specialist, or clinical trial directly with the hospital before making a treatment decision.
Targeted Therapy Cost in India
The cost of targeted therapy in India varies widely.
The final price can depend on:
- Specific medicine
- Brand or generic version
- Dosage
- Treatment duration
- Hospital
- Pharmacy
- Molecular testing
- Monitoring tests
- Insurance coverage
- Patient assistance programs
Online prices should not be treated as fixed national prices.
A hospital or oncology pharmacy should provide a current estimate based on the specific medicine prescribed to the patient.
Ask for an Itemized Cost Estimate
Before starting treatment, ask the hospital for a written estimate covering:
- Doctor consultations
- Molecular testing
- Targeted medicines
- Blood tests
- CT or PET-CT scans
- Hospital visits
- Supportive medicines
- Follow-up monitoring
This gives the patient a clearer idea of the total lung cancer treatment cost.
Can Health Insurance Cover Targeted Therapy?
Insurance coverage depends on the individual policy.
Before starting treatment, check:
- Targeted medicine coverage
- Outpatient medicine coverage
- Inpatient coverage
- Cashless treatment
- Sum insured
- Co-payment
- Waiting periods
- Sub-limits
- Pre-authorization
- Network pharmacy arrangements
Do not assume that every cancer medicine is automatically covered.
Ask the insurer for confirmation before starting expensive long-term treatment.
Patient Assistance Programs
Targeted medicines can be expensive, particularly when treatment continues for several months.
Depending on eligibility, patients may be able to explore:
- Manufacturer assistance programs
- Medicine discount programs
- Generic alternatives
- Government-supported programs
- Hospital financial assistance
- Insurance reimbursement
Patients should discuss lower-cost options with their oncologist before changing or stopping any prescribed medicine.
Questions to Ask Before Starting Targeted Therapy
Diagnosis
- What type of lung cancer do I have?
- What stage is it?
- Is it NSCLC or SCLC?
- Has the cancer spread?
Molecular Testing
- Which biomarkers were tested?
- Was comprehensive molecular testing performed?
- Was PD-L1 tested?
- Is another biopsy required?
Treatment
- Is targeted therapy suitable for my mutation?
- Which medicine is recommended?
- Why is this medicine preferred?
- How long will treatment continue?
- What happens if the cancer progresses?
Cost
- What is the expected medicine cost?
- What monitoring tests are required?
- Does insurance cover the medicine?
- Are assistance programs available?
Side Effects
- What side effects are common?
- Which symptoms need urgent medical attention?
- How will side effects be monitored?
Side Effects of Targeted Therapy
Targeted therapy can cause side effects, and the risks depend on the specific medicine.
Possible side effects include:
- Skin rash
- Diarrhea
- Fatigue
- Loss of appetite
- Nausea
- Changes in liver tests
- Swelling
- Blood pressure changes
- Heart-related effects with some medicines
- Lung inflammation with some treatments
Patients should report new or worsening symptoms to their oncology team rather than stopping treatment on their own.
Can Targeted Therapy Cure Lung Cancer?
The answer depends on the cancer stage, molecular changes, treatment response, and individual patient factors.
Targeted therapy can provide significant benefits for some patients whose tumors have actionable mutations.
However, a treatment response does not guarantee a cure.
In advanced cancer, treatment may control the disease for a period of time. Some cancers can eventually develop resistance to targeted medicines.
Regular scans, examinations, and other monitoring help doctors assess how well treatment is working.
What Happens If Targeted Therapy Stops Working?
Cancer can sometimes develop resistance to targeted treatment.
If the cancer progresses, an oncologist may consider:
- Repeat molecular testing
- Liquid biopsy
- Tissue biopsy
- Another targeted medicine
- Chemotherapy
- Immunotherapy
- Radiation therapy
- Surgery
- Clinical trials
The next treatment depends on the reason for progression and the molecular changes found at that time.
Why Consider a Second Opinion?
A second opinion can be useful when:
- The cancer is advanced
- A rare mutation has been found
- Molecular testing is incomplete
- Several treatment options are available
- Targeted therapy has been recommended
- Treatment costs are high
- Clinical trials are being considered
A second opinion can provide another specialist assessment before making an important treatment decision.
Final Takeaway
Targeted therapy has changed lung cancer treatment in India, especially for patients with non-small cell lung cancer whose tumors have actionable molecular changes.
The right treatment should be based on:
- Cancer type
- Cancer stage
- Molecular test results
- Overall health
- Previous treatment
- Oncologist’s recommendation
- Treatment cost
- Insurance coverage
Private hospitals such as Apollo Cancer Centres, HCG Cancer Centre, Fortis Memorial Research Institute, Manipal Hospitals, and Narayana Health may provide advanced lung cancer services, but the availability of specific medicines and testing can vary by location.
The most expensive or newest treatment is not automatically the best treatment.
Molecular testing and consultation with a qualified oncologist are essential before choosing targeted therapy.
Medical Disclaimer: This article is for educational purposes only. It is not a substitute for professional medical diagnosis or treatment. Targeted medicines have specific indications, risks, interactions, and monitoring requirements. A qualified oncologist should determine whether targeted therapy is appropriate for an individual patient.